Cabot (CBT) vs Methanex (MEOH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Methanex (MEOH) has outperformed Cabot (CBT) over the past year, gaining 58.1% versus a gain of 3.5%. Over five years, CBT leads with a +42.0% price change compared with +27.4% for MEOH. Methanex is the larger company by market cap ($4.80 billion vs $3.90 billion), about 1.2 times the size.
On valuation, Methanex trades at a lower forward P/E (10.2x vs 10.8x for Cabot). Cabot offers the higher dividend yield (2.41% vs 1.19%). Cabot converts more of its revenue into profit, with a net margin of 8.9% versus 4.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBT | MEOH |
|---|---|---|
| Share price | $75.61 | $62.04 |
| Market cap | $3.90B | $4.80B |
| 1-day change | +0.27% | +2.70% |
| YTD return | +14.08% | +56.19% |
| 1-year return | +3.53% | +58.06% |
| 5-year return | +41.99% | +27.42% |
| P/E ratio (TTM) | 21.18 | 61.43 |
| Forward P/E | 10.82 | 10.23 |
| EPS (TTM) | $3.57 | $1.01 |
| Dividend yield | 2.41% | 1.19% |
| Annual dividend | $1.82 | $0.74 |
| Revenue (latest FY) | $3.71B | $3.59B |
| Revenue growth (YoY) | -7.04% | -3.51% |
| Net income (latest FY) | $331.00M | $144.79M |
| Gross margin | 25.32% | 35.69% |
| Operating margin | 16.73% | 12.01% |
| Net margin | 8.91% | 4.03% |
| 52-week high | $94.53 | $66.75 |
| 52-week low | $58.33 | $32.00 |
| Distance from 52-week high | -20.01% | -7.06% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +19.47% | +13.31% |
| Average volume | 416.44K | 822.19K |
| Shares outstanding | 51.63M | 77.36M |
| Employees | 4,064 | 1,649 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MEOH has outperformed CBT by 54.5 percentage points over the past year.
- Methanex trades at a higher earnings multiple (61.4x vs 21.2x trailing P/E).
- Cabot offers a meaningfully higher dividend yield (2.41% vs 1.19%).
About Cabot
CBT stock →Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals.
Industrials · Major Chemicals · 4,064 employees
About Methanex
MEOH stock →Methanex Corporation engages in the production and sale of methanol and ammonia in Asia Pacific, North America, Europe, and South America. It also owns and leases in-region storage and terminal facilities.
Industrials · Major Chemicals · 1,649 employees
CBT vs MEOH FAQ
Which is bigger, Cabot or Methanex?
Methanex (MEOH) is larger, with a market capitalization of $4.80B compared with $3.90B for Cabot (CBT).
Which stock has performed better over the past year, CBT or MEOH?
MEOH returned +58.06% over the past 12 months, compared with +3.53% for CBT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CBT or MEOH?
CBT has the lower trailing P/E at 21.2, versus 61.4 for MEOH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cabot or Methanex?
Cabot has the higher yield at 2.41%, compared with 1.19% for Methanex.
Are Cabot and Methanex in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.